Report Code : CVMI2412247 | Published Date : March 3, 2025
The global Allergy Immunotherapy Market was valued at 2.9 billion in 2023 and is projected to reach 6.7 billion by 2031, growing at a CAGR of 10.8%. Rising environmental allergies, increasing adoption of biologics, and patient preference for long-term solutions drive growth.
2024 Market Breakthroughs
- Biologic Therapies:
- ALK-Abelló’s Palforzia® (peanut allergy) sales up 65% YoY.
- Stallergenes’ Oralair® achieves 90% efficacy in pediatric trials.
- Sublingual Tablets (SLIT):
- FDA fast-tracks 3 new grass pollen SLIT therapies.
- SLIT adoption grows 25% annually in Europe.
- Personalized Vaccines:
- DBV Technologies’ Viaskin™ Patch for milk allergy enters Phase III.
Market Drivers
1. Epidemic-Level Allergy Rates
- 30% global population suffers from allergic rhinitis (WHO).
- Pediatric food allergies up 72% since 2000.
2. Regulatory Support
- FDA’s 2024 Guidance: Expedited Review for Allergy Biologics.
- EU’s ATMP Classification: Cell-based immunotherapies are gaining R&D funding.
3. Patient Demand for Curative Solutions
- 70% of patients prefer immunotherapy over antihistamines (AAAI survey).
- 85% adherence rate for SLIT vs. 45% for injections (SCIT).
Competitive Landscape
Company |
Market Share |
Flagship Product |
Strategic Edge |
ALK-Abelló |
32% |
Palforzia® (Peanut) |
FDA-first biologic approval |
Stallergenes Greer |
24% |
Oralair® (Grass Pollen) |
SLIT market leader |
DBV Technologies |
15% |
Viaskin™ Patch (Milk) |
Non-invasive innovation |
Emerging Disruptors:
- Circassia’s ToleroMune®: T-cell tolerance therapy (Phase II).
- Anergis’ Ultra-Short Course: 4-injection regimen for pollen allergies.
Market Segmentation
- By Product:
- Subcutaneous (SCIT) (55%): Traditional allergy shots.
- Sublingual (SLIT) (XX%): Tablets/drops (growing at 18% CAGR).
- Epicutaneous (XX%): Patches (Viaskin™).
- By Allergy Type:
- Respiratory (XX%): Pollen, dust mites.
- Food (XX%): Peanut, milk.
- By Region:
- North America (45%): High biologic adoption.
- Europe (XX%): SLIT dominance.
- Asia-Pacific (XX%): Untapped potential.
Recent Developments (2024)
- April 2024: FDA approves Stallergenes’ 5-grass SLIT tablet.
- July 2024: ALK-Abelló partners with Sanofi on mRNA allergy vaccines.
Reasons To Buy

Scope

Key Players
- Allergy Immunotherapy Market – Stallergenes Greer
- ALK-Abelló A/S
- Merck KGaA
- Allergy Therapeutics
- HAL Allergy Group
- DBV Technologies
- Jubilant HollisterStier
- Anergis SA
- Biomay AG
- Circassia Pharmaceuticals.
Global Allergy Immunotherapy Market Report
Global Allergy Immunotherapy Market Report
- 1. Global Allergy Immunotherapy Market Research Report
- 1.1 Study Objectives
- 1.2 Global Allergy Immunotherapy Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Allergy Immunotherapy Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Allergy Type
- 2.1.3 By End-user
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Allergy Type, By End-user, By Country
- 3.3. Opportunities – By Type, By Allergy Type, By End-user, By Country
- 3.4. Trends – By Type, By Allergy Type, By End-user, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Allergy Immunotherapy Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Subcutaneous Immunotherapy (SCIT)
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Sublingual Immunotherapy (SLIT)
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Seasonal Allergies
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Perennial Allergies
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Food Allergies
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Others
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Clinics
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Homecare.
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Allergy Immunotherapy Market - Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Region, 2024 - 2031
- 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Subcutaneous Immunotherapy (SCIT)
- 9.1.2 Sublingual Immunotherapy (SLIT)
- 9.2.1 Seasonal Allergies
- 9.2.2 Perennial Allergies
- 9.2.3 Food Allergies
- 9.2.4 Others
- 9.3.1 Hospitals
- 9.3.2 Clinics
- 9.3.3 Homecare.
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Allergy Immunotherapy Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Subcutaneous Immunotherapy (SCIT)
- 10.1.2 Sublingual Immunotherapy (SLIT)
- 10.2.1 Seasonal Allergies
- 10.2.2 Perennial Allergies
- 10.2.3 Food Allergies
- 10.2.4 Others
- 10.3.1 Hospitals
- 10.3.2 Clinics
- 10.3.3 Homecare.
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Allergy Immunotherapy Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Subcutaneous Immunotherapy (SCIT)
- 11.1.2 Sublingual Immunotherapy (SLIT)
- 11.2.1 Seasonal Allergies
- 11.2.2 Perennial Allergies
- 11.2.3 Food Allergies
- 11.2.4 Others
- 11.3.1 Hospitals
- 11.3.2 Clinics
- 11.3.3 Homecare.
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Allergy Immunotherapy Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Subcutaneous Immunotherapy (SCIT)
- 12.1.2 Sublingual Immunotherapy (SLIT)
- 12.2.1 Seasonal Allergies
- 12.2.2 Perennial Allergies
- 12.2.3 Food Allergies
- 12.2.4 Others
- 12.3.1 Hospitals
- 12.3.2 Clinics
- 12.3.3 Homecare.
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Allergy Immunotherapy Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Subcutaneous Immunotherapy (SCIT)
- 13.1.2 Sublingual Immunotherapy (SLIT)
- 13.2.1 Seasonal Allergies
- 13.2.2 Perennial Allergies
- 13.2.3 Food Allergies
- 13.2.4 Others
- 13.3.1 Hospitals
- 13.3.2 Clinics
- 13.3.3 Homecare.
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Allergy Immunotherapy Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Allergy Immunotherapy Market – Stallergenes Greer
- 14.2.2 ALK-Abelló A/S
- 14.2.3 Merck KGaA
- 14.2.4 Allergy Therapeutics
- 14.2.5 HAL Allergy Group
- 14.2.6 DBV Technologies
- 14.2.7 Jubilant HollisterStier
- 14.2.8 Anergis SA
- 14.2.9 Biomay AG
- 14.2.10 Circassia Pharmaceuticals.
16. Principal Presumptions and Acronyms